Mark HELLMICH
5Patents
2h-index
4Co-inventors
44Inventor score
Filing activity: Dec 17, 1990 → Dec 14, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5831074A | Eucaryotic NAD cyclases | Human Necessities | 2 | Expired |
| US5393667A | Eucaryotic NAD cyclases | Emerging Cross-Sectional Technologies | 2 | Expired |
| US5202426A | Eucaryotic NAD cyclases | Emerging Cross-Sectional Technologies | 2 | Expired |
| US10335382B2 | Use of hydrogen sulfide synthesis inhibitors for cancer therapy | Chemistry; Metallurgy | 0 | Active |
| US9868715B2 | Apigenin analogs, compositions, and methods related thereto | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.